Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.39)
# 2,571
Out of 4,981 analysts
25
Total ratings
50%
Success rate
11.94%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $37.00 | +48.65% | 1 | Sep 3, 2025 | |
| BWAY BrainsWay | Maintains: Outperform | $15 → $19 | $15.77 | +20.52% | 4 | Aug 14, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $25.51 | +21.52% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.61 | +171.15% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.94 | +209.28% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $1.30 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $15.01 | +66.56% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $3.79 | +6,232.45% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $19.76 | +304.86% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $6.94 | +231.41% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.84 | +745.07% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.36 | +84,645.76% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.26 | - | 1 | Sep 27, 2017 |
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $37.00
Upside: +48.65%
BrainsWay
Aug 14, 2025
Maintains: Outperform
Price Target: $15 → $19
Current: $15.77
Upside: +20.52%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $25.51
Upside: +21.52%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.61
Upside: +171.15%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.94
Upside: +209.28%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $1.30
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $15.01
Upside: +66.56%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $3.79
Upside: +6,232.45%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $19.76
Upside: +304.86%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $6.94
Upside: +231.41%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.84
Upside: +745.07%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.36
Upside: +84,645.76%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.26
Upside: -